GlucoTrack, Inc.
- GCTK
- NASDAQ
- Medical devices
- Non-invasive Glucose Monitoring
- Diabetes Care Devices
$0.68
Today −5.56%Quote Oct 19, 2026, 08:00 PM UTC
−72.28%over the last month
Max drawdown −73.5%From 1-month high −73.5%3 months −87.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About GlucoTrack
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
15
Market value
$7.2M
Quote Oct 19
Floor
$0.55
19.2% below price
Resistance
$0.88
28.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GCTKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free